
Bill Kristol @BillKristol
"There is no FDA pathway for tests to be evaluated and approved for use in a regimen rather than as a single test or for their public health potential to reduce community transmission. The regulatory lens remains focused on clinical diagnostic tests..." https://t.co/1Oa2dibYIP — PolitiTweet.org